Press Release Jun 03 2026

About this update from Natco Pharma Limited

Natco Pharma Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "NATCO Pharma Limited and Lupin Limited receive approval from U.S. FDA for Eribulin Mesylate Injection". View Attachment

View stock analysis, news, and events for Natco Pharma Limited